secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2022-05-17T23:59:59+00:00
Accession:  0001193125-22-153071
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta signs 10-year lease for ~73k sq ft HQ expansion in Watertown, MA; amends existing leases
--------------------------------------------------------------------------------

- New lease with ARE-MA Region No. 75 for ~73,000 sq ft at Arsenal on the Charles; 10-year term starting June 2024.
- Aggregate minimum lease payments under new lease: ~$76.5M; base rent ~$0.6M/month with 3% annual escalations.
- Tenant improvement allowance of ~$15.0M; one-time extension option for additional 5 years at market rate.
- Second Amendment shortens 500 Arsenal St lease to ~June 2024; aggregate remaining payments ~$6.5M.
- First Amendment at 400 Talcott Ave adds ~20,000 sq ft office space; lease extended to June 2034; aggregate payments ~$19.4M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000119312522153071/0001193125-22-153071-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000119312522153071/d349963d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-153071

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer